Position in IMRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$578,066
-$216,897 QoQ
Shares Held
115,845
-23.2% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 111 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. IMRX ranks #238 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in IMRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $578,066 | 115,845 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $794,963 | 150,847 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,410,362 | 214,341 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $306,278 | 43,754 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $96,017 | 28,492 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $43,857 | 28,854 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $68,318 | 31,054 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $78,152 | 31,387 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $41,106 | 32,115 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $37,578 | 13,003 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $179,369 | 24,404 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $90,754 | 11,817 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $47,799 | 4,714 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $23,226 | 2,392 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,574 | 531 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $544 | 38 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,819 | 891 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $189,596 | 29,304 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $125,026 | 7,732 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $14,389 | 542 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||